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During  the  early phase  of transport  of exogenous fats,  lymph and  blood 
assume a milky appearance due to an increase of large fat particles, known as 
chylomicrons. Separation can be achieved by chemical means; protamine sulfate 
(1), toluidine blue (2), heparin and calcium chloride (3, 5), polyvinylpyrrolidone 
(4); however, ultracentrifugation (6) is the method commonly used. Chemical 
characterization of lymph and serum chylomicrons has not been satisfactorily 
achieved; this may be owing to: (a) variation of laboratory procedures, which 
do not yield a product of constant composition; (b) variation in source: human 
lymph (7-14),  human serum (12),  rat lymph (2,  15,  16), dog lymph (17,  18), 
and dog plasma  (19);  (c)  limited number of reports  on chylomicron compo- 
sition  and  lack  of  comparative  studies  between chylomicrons derived from 
lymph and blood. 
Another  problem  is  the  relationship  between  chylomicrons  and  serum 
lipoproteins. Robinson (15)  found no protein in chylomicrons separated from 
rat chyle; other reports (2, 9, 11, 14, 16, 17) however, show small percentages 
present in human and rat chyle chylomicrons. The nature of this protein is 
unknown. Middleton (20) reported the presence in human serum chylomicrons, 
of a protein antigenically related to serum beta lipoproteins. Recently, Robdell 
(21) found that serine, threonine, and aspartic acid are the N-terminals of the 
chylomicron protein from human lymph serum. 
Our study concerns: (a)  Separation, purification, and chemical composition 
of chylomicrons from serum of people in absorptive phase; (b) separation and 
characterization of their protein moiety; (c)  participation of the chylomicron 
protein  in a  clearing factor system "in  vitro";  (d)  comparison of the  chylo- 
microns  with  ultracentrifugally separated  creamy  top  fractions  from  pre- 
incubated mixtures of serum and coconut oil. 
Materials and Metkods 
Fasted normal human subjects received a fat breakfast containing approximately 1.5 
gm. of animal fat per kilo body weight. 500 ml. of blood was withdrawn 3 hours after the 
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meal and serum separated from clotted blood by centrifugation. Milky serum was stored at 
3°C.  no longer  than 24 hours before use. Occasionally,  analyses were performed on hyper- 
lipemic plasmas received from the blood bank. During the course of our experiments over 15 
liters of milky serum or plasma were studied. 
Separation  of Chylomicrons.--Step  1.  In 10 ml. plastic tubes, 5  ml. samples of serum or 
plasma were layered under 4 ml. 0.15 ,~ solution of sodium chloride and centrifuged at 9,000 
g for 10 minutes in a Spinco 30.2 rotor at 15°C. Top fractions were layered under 5 volumes of 
0.055 ~  phosphate pH 7 and recentrifuged at 35,000 g for 10 minutes. This process was then 
repeated up to 4 times to remove very low density lipoproteins (i.e.  --S 70 to 400). Step 2. 
Final top fractions from step 1, layered under phosphate buffer, were spun for additional 18 
hours at 105,000 g in a Spinco 40 rotor. After separation of the top fractions, bottom fractions 
were collected, concentrated by pervaporation, and  the  turbidity related to  residual lipides 
was removed by ultracentrifugation. Step 3.  Top fractions from step 2, layered under phos- 
phate buffer, were treated as in step 2. Top and bottom fractions were collected. 
Aliquots of top fractions from steps 1 and 2, bottom fractions from steps 2 and 3, and final 
chylomicron preparations (top step 3) were dialyzed against 0.15 ~t solutions of sodium chlo- 
ride, and then stored at 3°C. until used. 
Preparation of Emulsions of Serum and  Coconut 0//.--Aliquots of one liter of serum, from 
which chylomicrons had  been removed by ultracentrifugation, were  mixed with an equal 
volume of 1 per cent ediol,  1 a coconut oil emulsion, in phosphate buffer pH 7. The mixture was 
incubated for 2  hours at 37°C.,  then kept at 3°C.  for no longer than 24 hours until used. 
Separation and purification of the fat particles from the creamy emulsions were performed by 
applying the same procedure as for chylomicrons. 
Delipidation  Procedures.--Extraction  of chylomicrons by a  cold mixture 3:1 of ethanol- 
ethyl ether (22) or by a freezing and thawing procedure (23) yielded a protein residue insoluble 
in water. Only partial delipidation procedures were, therefore, applied. The following was the 
one commonly used: A sample of chylomicron (2 to 3 ml.) was gently shaken with ethyl ether 
at 3°C. and the mixture placed in a continuous liquid-liquid extractor to which a water jacket 
was applied around the extraction chamber so as to insure a  continuous flow  of tap water, 
cooled to a temperature of 3°C. Ether extraction was conducted continuously for 12 hours until 
the chylomicron solution did not show visible turbidity. At the end of this process the ether 
phase was aspirated and traces of ether in the water phase removed by a stream of nitrogen. 
In some instances, in which prolonged delipidation was not required, as for immunological 
studies, chylomicrous, after being shaken with cold ether, were spun at 30,000 R.r.~. in the 
International refrigerated centrifuge. After separation of the ether phase a fairly clear sample 
was obtained. 
Studies on the delipidized protein residue had to be performed immediately after lipide 
removal, because of the tendency of the protein to precipitate. Lyophilization was attempted; 
this  procedure,  however,  reduced  the  solubility  of  the  chylomicron protein. 
Chemical Composition.--Protein concentration was determined by the Lowry method (24). 
When lipemic samples were analyzed, however, turbidity had to be removed by shaking the 
solution with ether after the blue color had fully developed.  Accuracy of this method was 
checked  by  Pregl's  modification  of  the  Kjeldahl  method  (25). 
Total lipides were determined gravimetrically by Sperry's method  (26).  Cholesterol was 
determined by the method of Abell et al.  (27). Phospholipides were calculated by multiplying 
lipide phosphorus values, obtained by the method  of Fiske and Subbarow (28)  by 25.  Tri- 
glyceride values were obtained by the method of Van Handel and Zilversmit (29). Hexosa- 
mine content was estimated by the method of Neuhaus and Letzring (30). 
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Electrophoresis.--Moving  boundary  electrophoresis was  determined  by  the  Longsworth 
modification of the Tiselius method employing barbital buffer at pH 8.6, ionic strength 0.1/a. 
Paper electrophoresis was performed using a  Durrum  (31)  cell with a  barbital buffer of 
pH 8.6,  ionic strength 0.05 #.  Bromophenol was used for protein staining; Sudan black for 
lipide staining. 
Agar electrophoresis was performed according to the technique previously described (22). 
Sedimentation diagrams were obtained in Spinco analytical ultracentrifuge at 52,640 R.r.M. 
at a temperature of q-20°C. 
Immunological  Sttdies.--Specific  antisera were  obtained  by immunizing rabbits against 
one  of  the  following antigenic solutions: human crystalline serum albumin, human serum 
alpha1  lipoprotein or fasting normal human serum. Immunizing solutions were precipitated 
with alum hydroxide before injection.  Each rabbit received an intraperitoneal injection at 
the beginning of the week and one intravenous injection on each of the following 3 days. The 
procedure,  increasing the amount  of antigen each  week,  was  repeated 4  weeks  for a  total 
amount of 100 mg. of antigen injected. Rabbits were hled on the 7th day after the final in- 
jection. 
Commercial equine anti-normal human serum  lot 581,  ol)tained from  Pasteur Institute, 
was also used. 
Specific  absorbed  antisera were  obtained  by  adding  increasing amounts  of  albumin or 
alphal or beta lipoprotein  (ether extracted)  to anti-normal human serum.  Specific  antisera 
against  beta  lipoprotein were  prepared  according to  Burstein's method  (32). 
Immunochemical  analyses  were  performed  hy  the  previously  described  techniques  of 
agar  immunoelectrophoresis  and  agar  double  diffusion  (21). 
Assays fi~r "Clearing Factor."--A partially purified preparation of enzyme was  obtained 
from post-heparin human I)lasma according to the method of Nikkiltt (33). To avoid presence 
of alpha lipoproteins in the precipitate, the procedure was carried out at pH  6.5.  Assays of 
clearing activity were determined by fall in optical density production of non-esterified fatty 
acids  (NEFA)  according  to  techniques  previously  described  (34). 
An assay of clearing activity in agar plates was also investigated. 30 gm. of agar (Bacto 
Difco) was dissolved in 400 ml. of hot distilled water. After cooling, the solidified agar, cut in 
small pieces, was washed for several days with distilled water. The agar was then added to 
hot phosphate buffer pH 7 to obtain a  1.5 per cent solution. 20 ml.  aliquots were poured in a 
Petri dish and mixed with 2.5 ml. of 1 per cent solution of bovine serum albumin, both solu- 
tions made in phosphate buffer pH  7.  This mixture yielded an uniformly opaque substrate, 
in which round wells,  7 ram. in diameter, were cut to contain the enzyme preparation. The 
plates were incubated at 37°C., usually for 6 hours; enzymatic activity was indicated by the 
appearance  of  clear  rings around  the  wells. 
"Finger  Printing"  Technique.--A  modification  of  Ingram's  technique  was  used  (35). 
Heat-denatured  protein samples  (1  mg.)  were  digested  by 25/zg.  of trypsin for 2 hours in 
ammonium  carbonate  buffer  at  t)H  8.2.  Electrophoretic  and  chromatographic  separation 
of the partial hydrolysate was performed in a large sheet (31 x 29 cm.) of Whatman paper 3 
MM.  Electrophoretic separation was obtained in  1 hour in a  Durrum cell with an acetate 
buffer (pH 5.5,/z 0.025), a potential gradient of 11  V/cm., and a current of 50 milliamperes. 
Chromatographic separation  was  achieved  by a  solvent system  3:1:1  of n-butanol-acetic 
acid-water.  Spots  were  revealed  by  ninhydrin  spray. 
RESULTS 
Studies  on  Chylomicrous.--Top  fractions  of  Step  1,  extracted  with  ether, 
gave  a  protein  solution  of  a  concentration  ranging  from  1  to  1.5  per  cent. FIG.  1.  Moving boundary  electrophoresis,  immunoelectrophoresis and  diagram  of  sedi- 
mentation of a  preparation of top fraction step  1,  partially delipidized by ethyl ether.  A: 
Tiselins pattern.  (a) normal serum.  (b) Top fraction step 1, delipidized. B: Agar  immunoelec 
trophoretlc pattern.  Antigen, top fraction step  1, delipidized, 70/zg. N. Antiserum, equine anti- 
normal human serum, 700/~g. N. The antigen was separated electrophoretically; the antiserum 
was then added. Time of diffusion, 8 days.  Stain, azocarmine. C: Agar immunoelectrophoretic 
pattern.  Antigen and antiserum, same as B. The antiserum was separated electrophoretically; 
the antigen was then added. Time of diffusion and stain, same as B. D: Diagram  of sedimenta- 
tion.  0.2 per cent partially delipidized top fraction, step 1 in 0.9 per cent sodium chloride at 
+20°C.; 52,460 1~.~.~.; time, 32 minutes. 
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Because of the instability of this solution on standing, analysis had to be per- 
formed in the first 3 to 4 hours after partial removal of the lipides. The results 
are shown in Fig.  1. Tiselius pattern (Fig.  1 A b) shows the presence of three 
main  components with  the mobility of albumin,  alpha and beta globulins.  A 
greater heterogeneity is,  however, shown  by the  two immunoelectrophoretic 
patterns  (Figs.  1 B  and  1 C)  which  indicate  at  least  5  different  antigenic 
determinants.  Similar results were obtained with  the  double  diffusion  tech- 
nique  of  Ouchterlony.  The  sedimentation  diagram  (Fig.  1 D)  corroborated 
the findings. 
The results  of  the  analysis  of  the  bottom  fractions of Steps  2  and  3  are 
summarized  in  Fig.  2.  Several  serum  components  (albumin,  alphab  alpha2, 
and beta globulin) were detected by agar electrophoresis (Fig. 2 A) in the bot- 
tom  fractions  of step  2,  which  showed  a  protein  concentration  of  approxi- 
mately  2  per  cent.  Immunoelectrophoresis  (Fig.  2 B  and  2 C)  gave  several 
lines of precipitation. 
The maximum protein concentration observed in bottom fractions of step 3 
was  between 0.06 and 0.08 per cent. Agar electrophoresis (Fig.  2 D)  showed 
only two  boundaries  stainable  with  amido  Schwartz  or  Sudan  black.  With 
these two serum  components, identified as alpha1 and beta lipoproteins,  im- 
munoelectrophoresis (Figs.  2 E  and  2 F)  and the agar double diffusion tech- 
nique (Fig. 2 G) revealed a third line of precipitation, albumin. 
The results of the analysis of the chylomicron fractions after the final wash- 
ing (top fraction of step 3) are shown in Fig. 3. After delipidation with ether, 
a maximum protein concentration of 0.08 per cent was obtained. This protein 
was more unstable than the chylomicron protein from step  1. Because of the 
low protein level a  Tiselius pattern  could not be obtained.  A  sedimentation 
diagram (Fig. 3  D) revealed a small, flat peak,  almost identical in position  to 
the peak of a  delipidized alpha1  lipoprotein sample (22). Agar electrophoresis 
(Fig.  3A)  showed  two  faint  boundaries  stainable  with  amido  Schwartz: 
densitometry evaluation  gave  an  approximate  ratio  of  the  slow  to  the  fast 
moving component of  1:3.  Immunoelectrophoresis (Figs.  3 B  and 3 C)  gave 
two lines of precipitation, one for each boundary. Position of the boundaries 
and shape of the lines of precipitation were identical with those exhibited by 
samples of serum beta and alpha1  lipoprotein, extracted with ether. The data 
obtained by the double diffusion technique corroborated these findings  (Fig. 
3 E).  Furthermore,  absorption  experiments  showed  disappearance  of one or 
the other line of precipitation when equine anti-human  serum was  absorbed 
with either alpha1 or beta serum lipoprotein. 
Attempts  were made  to obtain a  chylomicron preparation completely free 
of protein.  Further washings,  however, did not  remove appreciable amounts 
of protein from the purified chylomicrons. At this stage a clumping phenomenon 
may also occur. 244  HUMAN  SERUM  CHYLOMICRONS 
Bottom fraction--step 2 
F1G. 2.  Agar electrophoresis and immunochemical analyses of undelipidized bottom frac- 
tions of steps 2 and 3. A: Agar electrophoretic pattern. Bottom fraction, step 2, 70 #g. N. Stain, 
amido Schwartz. B: Agar immunoelectrophoretie pattern. Antigen, bottom fraction step 2,  70 
pg. N. Antiserum, equine anti-normal human serum, 700/zg.  N.  The antigen was separated 
electrophoretically; the antiserum was then added. Time of diffusion, 8 days. Stain, azoearmine. 
C: Agar immunoelectrophoretic pattern. Antigen and antiserum, same as B. The antiserum was 
separated electrophoretically; the antigen was then added. Time of diffusion and stain, same 
as B.  D: Agar  electrophoretic pattern. Bottom  fraction, step 3,  70/zg.  N.,  E: Agar immuno- 
electrophoretic pattern.  Bottom  fraction,  step  3.  Same  as  B.  F:  Agar  immunodectrophoretic 
pattern. Bottom fraction, step 3.  Same as C. G: Agar double diffusion technique. Central well, 
equine anti-normal human serum. (1) alpha1 lipoprotein preparation containing trace amounts 
of albumin. (2) and (4) undelipidized bottom fraction, step 3.  (3) Mixture of alphaa and beta 
lipoprotein containing trace amounts of albumin. A.  SCANU  AND  I.  H.  PAGE  245 
Bottom fraction--step 3 
FIG. 2--comluded 246  HUMAN  SERUM  CHYLOMICRONS 
FIo. 3. Agar electrophoresis, immunochemical analyses and diagram of sedimentation of a 
final  chylomicron preparation  (top  fraction,  step  3),  partially  delipidized  by  ethyl  ether. 
A: Agar  dectrophoresis. Top  fraction,  step  3,  partially delipidized,  70/zg.  N.  Stain,  amido 
Schwartz. B: Agar irnmunodectrophoretlc pattern. Antigen, same as A, 70/~g.  N. Antiserum, 
equine anti-normal human  serum, 700/zg. N. The antigen was separated  electrophoretically; 
the antiserum was then added. Time of diffusion,  8 days. Stain, azocarmine. B': Detail from A.  SCANU  AND  I.  H.  PAGE  247 
Frc. 3--conduded 
B. C: Agar immunoelectrophoretic pattern. Antigen and antiserum, same as B. The antiserum 
was separated electrophoretically; the antigen was then added. Time of diffusion and  stain, 
same as B. D: Diagram of sedimentation. 0.08 per cent partially defipidized top fraction, step 
3, in 0.9 per cent sodium chloride at  +20°C.; 52,460 ~.P.M.;  time 32 minutes. E: Agar double 
diffusion  technique. Central  well, partially  delipidized top  fraction,  step 3.  (1)  equine  anti- 
normal human  serum.  (2)  Mixture  of anti-human  alpha~  and  anti-human  beta  lipoprotein 
sera.  (3)  Anti-human albumin  serum.  (4)  Anti-human  beta lipoprotein serum.  The lines of 
precipitation present between wells 1 and 4  and wells 1 and 2  are due to antigenic determi- 
nants in wells 2  and 4, which reacted with the antiserum in well 1. 248  HUMAN  SERUN[  CHYLOMICRONS 
Studies on Mixtures of Serum and Coconut Oil.--Analyses  of top and bottom 
fractions  resulting  from  the  three  different preparative  steps,  showed  data 
very  similar  to  the  ones  reported for chylomicrons. The  final  creamy  top 
fractions (step 3) yielded, after delipidation, a protein solution of a maximum 
concentration of approximately 0.1 per cent. Agar immunoelectrophoresis and 
agar double diffusion technique revealed presence of beta and alpha iipoproteins 
in almost the same proportion as in chylomicrons. 
Chemical  Composition  of  Chylomicrons  and  Particles  from  Serum-Coconut 
Oil  Emulsion.--The  results,  shown  in  Table I,  indicate  a  higher percentage 
of cholesterol and phospholipide in the chylomicron fraction than in the serum- 
coconut oil emulsion. It must be borne in mind, however, that the factor 25, 
TABLE I 
Chemical Composition of Serum Chylomicrons and Fat Particles  from a Mixture of Serum and 
Coconut Oil Emulsion 
I 
i  Chylomicrons  Fat particles from serum- 
coconut oil emulsion 
per cent* 
Total  cholesterol ...................  I  4.2-4.6 
Phospholipides:~ ....................  ]  8.9-9.6 
Triglycerides  .......................  i  85.0-88.0 







* Percentage is based on total lipide weight. 
Expressed as lecithin (P X 25). 
used for phospholipide values, is arbitrary. We are not sure that  these phos- 
pholipides were lecithin. 
Recovery experiments performed during  the procedure of lipide extraction 
revealed that  ether removed from the  chylomicron fraction  100  per  cent of 
the triglyceride, 80 per cent of the cholesterol, and 50 per cent of the phospho- 
lipides.  When attempts  were made to remove the  lipides totally by alcohol- 
ether, the protein residue was insoluble in water. 
One liter of plasma yielded 20 to 25 ml. of packed chylomicrons, containing 
15  to 20 rag.  of total lipides per milliliter. Therefore, the serum  chylomicron 
concentration of our subjects in the absorptive phase was approximately 0.04 
to 0.05 gin. per cent. 
Experiments  on  "Clearing  Factor".--The  enzyme preparation,  precipitated 
from post-heparin  plasma,  was  inactive when  tested  against  a  coconut  oil 
emulsion,  used  as  a  substrate.  Activity was  induced  by  pre-incubating  the 
substrate with serum alphas lipoprotein. Clearing activity was  indicated by a 
50 per cent fall in optical density and increased NEFA production (1.6 m.eq./l.). A,  SCANU  AND  I.  H.  PAGE  249 
Agar plate assay showed enzyme activity, by appearance of a  clear ring in the 
opaque gel, when alpha1 lipoprotein was present either in the substrate or in the 
well with  the  enzyme.  Substitution  of  the  alphax  lipoprotein  with  partially 
delipidized  samples  of  either  chylomicrons  or  serum-coconut  oll  mixture, 
produced a  clear ring (see Fig. 4 b). 
FIG. 4.  Determination of "clearing factor" activity in agar plates. (a): Bovine  albumin 
and a coconut oil emulsion  were mixed in agar to give an opaque  gel  (see text) in which  7 
round wells were cut.  An enzyme  preparation (post-heparin plasma) was  added to wells 1 
through 5 in decreasing concentrations. Well 6 contains normal human serum; well 7, saline. 
Time of incubation: 6 hours.  (b):  Substrate, same as  (a).  The 4 wells contain an enzyme 
preparation precipitated from post-heparin plasma (see text). In addition the following prepa- 
rations were added: well 1, serum alphal lipoprotein; well 2, partially  delipidized chylomicrons; 
well 3, partially delipidized particles from a  mixture of serum-coconut oil. Well 4 contains 
the enzyme preparation only. 
Chylomicrons or coconut oil-serum mixture, both undelipidized, were mixed 
with agar. These substrates tested against the enzyme preparation from post- 
heparin plasma exhibited a  clear ring. 
Another  series of  experiments  in  agar  proved that alpha1  lipoprotein,  still 
active when  partially delipidized by ether,  did not  show  activity when  com- 
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FIo.  5.  "Finger prints" of  (a)  protein from serum chylomicrons,  (b) protein from a  pre- 
incubated mixture of serum-coconut oil.  These proteins, heat-denatured, were partially di- 
gested by trypsin. The components of the hydrolysate were separated,  on  a  large sheet of 
filter paper by electrophoresis (11 volts/cm., 50 milliamperes, 1 hour) and ascending chroma- 
tography (solvent system: n-butanol, acetic acid, water 3:1:1). Detection of the spots, nin- 
hydrin spray. A. SCANU  AND  I. H. PAGE  251 
the  enzyme  or  the  agar  substrate  did  not induce  activity.  Activation  was, 
however, induced by a mixture of alpha and beta lipoproteins. 
Experiments with the "Finger Printing"  Technique.--Our results are limited 
to  a  comparative  analysis  of  the  proteins  obtained  by partial  delipidation 
of chylomicrons and of serum-coconut oil mixture. Similar,  though not identi- 
cal,  patterns were obtained. A few extra spots were observed in the chymo- 
micron protein pattern (see Fig. 5). 
The yield of chylomicron protein was too small  to permit  separation  and 
comparison of each of its two components with the patterns of either alpha or 
beta lipoprotein, obtained in preliminary experiments. 
DISCUSSION 
Our greatest limitation  has been the low yield of protein from chylomicrons 
and from the final washed particles from the serum-coconut oil emulsion. 
Highly sensitive  immunochemical  methods  were valuable in the characteriza- 
tion of these protein moieties. Other techniques, performed in parallel when 
sufficient  material  was available,  corroborated these  findings. 
Analysis of the products of the different steps of chylomicron  preparation 
showed that low speed ultracentrifugation  for short periods does not remove 
many of the serum components. High  speed u]tracentrifugation  for prolonged 
periods, removed all but a small amount of protein, which  constitutes  approxi- 
mately 2 per cent of total lipide weight of the chylomicrons.  This yield  was 
fairly constant and did not change  with further high speed ultracentrifugation. 
Alphal and beta lipoproteins were found to be present in the final washed 
chy]omicron fraction since: (a)  two boundaries with the migration rates of 
intact or partially delipidized alphal and beta ]ipoproteins were detected by 
paper and agar e]ectrophoresis; (b)  two lines of precipitation similar  to those 
exhibited by intact or delipidized serum alphal and beta lipoproteins were 
shown by immunoelectrophoresis and agar double diffusion  technique; (c) one 
or the other of the two lines of precipitation disappeared when antisera ab- 
sorbed with either alphal or beta lipoproteins were used; (d) one specific line 
of precipitation appeared with immune sera anti-a]phal or  anti-beta ]ipo- 
protein. 
Middleton found, on  the basis of immunological studies, that Ss 3 to 8 
beta ]ipoproteins are present in chy]omicrons (20). We think,  however, that 
his immunochemical  methods and the ones used in our experiments cannot 
classify beta  lipoproteins according to  ultracentrifugal flotation since low 
density lipoproteins have a common antigenic  determinant (23, 35). The find- 
ing that the protein bound to chy]omicrons  is quite unstable  after  delipidation, 
is also indicative  of the presence of beta lipoproteins. This class of molecules 
undergoes rapid denaturation  after removal of ]ipides (23). 
Our results have also shown that a coconut oil emulsion added to a large 252  HUMAN  SERU~  CHYLOMICRONS 
volume of serum freed of chylomicrons, picks up a minute amount of protein 
which is not removed by high speed ultracentrifugation. This protein is very 
likely a constituent of the beta and alpha1 lipoproteins whose presence in the 
ultracentrifugally separated particles of coconut oil was detected by the same 
methods  used  for  chylomicrons. The  relative  proportion  between  the  two 
lipoproteins present in the final washed product from serum-coconut oil emul- 
sion was found also very similar to the one in chylomicrons. The data with the 
"finger printing"  technique  seem  to  corroborate  these  findings, although  a 
few extra spots were found in the chylomicron pattern.  These might be at- 
tributed to a  slight difference in proportion of alphal and beta lipoproteins in 
the two classes of molecules. 
Frazer  has  shown  that  addition of serum  to  fat  emulsions stabilizes  the 
fat particles; when serum is defatted this activity is lost (37).  This, and our 
demonstration that these fat particles pick up lipoproteins from serum upon 
incubation,  lead us  to  believe  that  lipoproteins  are  responsible  for  the  fat 
stabilizing activity of serum. It is possible that a  similar mechanism occurs 
"in vivo" during the absorptive phase when large fat particles reach the blood 
stream and come in contact with the serum lipoproteins. This may give an 
explanation for the findings that lipoproteins are present in chylomicrons and 
that serum chylomicrons migrate with the alpha (11, 37, 38) and beta globulin 
fractions (37,  38).  Because human lymph was not available for study we do 
not know  whether  lipoproteins  are  also  present  in  chyle chylomicrons. Ac- 
cording  to  Frazer  (37)  chylomicrons from  chyle are  different from serum 
chylomicrons in the sense that they have different electrophoretic mobility and 
different stability when exposed to the action of the lecithinase of Clostridium 
welchii.  Bragdon (16)  found that the protein concentration of chylomicrons 
from  rat  chyle  is  significantly lower  than  that  reported  for  chylomicrons 
from rat serum. 
The demonstration that particles of coconut oil incubated with serum re- 
tained lipoproteins,  was supported by chemical analyses, which showed the 
presence of protein, cholesterol, and phospholipide in proportions compatible 
with a lipoprotein molecule. In chylomicrons the concentrations of cholesterol 
and phospholipides were higher than would have been expected ff only cho- 
lesterol and phospholipides of the serum lipoproteins that we assume attached 
to  chylomicrons, were  present.  It  is  likely that  this  "excess" derives from 
exogenous sources during the process of intestinal absorption of fats and, more 
precisely,  from the  cholesterol  directly absorbed  from the  intestinal  lumen 
and from the phospholipides,  which,  broken  down prior  to  absorption,  are 
resynthesized in the intestinal mucosa. These phospholipides may participate 
in surface phenomena and contribute to the stability of the chylomicrons. 
The hexosamine fraction demonstrated in chylomicrons and particles from 
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We have shown that hexosamine is one of the components of the serum alphat 
lipoprotein (22). 
Further supportive evidence for the presence of alpha1  lipoprotein in purified 
preparations  of chylomicrons and  particles  from coconut  oil  absorbed  with 
serum, is given by our findings on "clearing factor" activity.  We showed, in 
accord with the data of Korn (39)  that of the serum components, alphat lipo- 
proteins  activate  an  otherwise  inactive  coconut  oil  substrate.  Partial  de- 
lipidation of the alpha1 lipoprotein sample or its addition to a beta lipoprotein 
solution  did  not  modify its  activity.  The  findings  that  only serum  alpha1 
lipoprotein activated the enzyme system,  and that protein from the partial 
delipidation of chylomicrons and serum-coconut oil mixture, immunologically 
identified as serum components, also induced enzyme activation, support  the 
presence of alphat lipoprotein in chylomicrons. In agreement with these  con- 
clusions are our data showing that substitution of the coconut oil, an inactive 
substrate,  with  undelipidized  chylomicrons  or  serum-coconut  oil  mixture, 
determines appearance of clearing activity in the system. 
Rodbell's data (12) which show aspartic acid as one of the three N-terminal 
amino acids of human serum chylomicrons, are also consistent with our find- 
ingsY It has been shown that aspartic acid is the N-terminal residue of human 
serum alphat lipoproteins (22, 40, 41). 
"Clearing  factor"  activity can  be  satisfactorily determined  by  using  a 
system which contains agar. Our results have shown that agar is a good, inert 
supportive medium for the  coconut oil  substrate;  the  enzyme diffuses in it 
without apparent denaturation, and shows its activity by clear areas in the 
opaque gel. Under standard conditions a  good correlation was found between 
concentration of enzyme and the area of clearing--a finding that suggests its 
use as an accurate and quantitative enzyme assay. 
The authors are indebted to Dr. Lena  A. Lewis for helpful discussion  during the course of 
this investigation. They also wish to thank Mrs. A. Scanu, Mrs. Daisy Johnson, Mr. Michael 
Kauker, Mr. S. B~r~ny, and Mr. A. Camma, recipient of a summer grant from the Cleveland 
Area  Heart  Society,  for  technical  assistance. 
SUMMARY 
Chylomicrons were  separated  by low  and  high  speed  ultracentrifugation 
from lipemic sera of human subjects in the absorptive phase. The final chylo- 
micron preparation was free from other serum components and contained a 
small constant amount of protein, approximately 2 per cent of the chylomicron 
2 At the Annual Meeting of the Federation of the American Societies for Experimental 
Biology of March, 1958, Philadelphia, Rodbell and Fredrickson presented evidence that alpha1 
lipoprotein is a  component of the human  chylomicron protein,  by N-terminal analysis and 
"finger printing" technique.  (Rodbell, M.,  and  Fredrickson,  D. S.,  Nature and function of 
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fraction.  Electrophoresis,  immunochemical analysis,  and  absorption  experi- 
ments identified the protein component as derived from a mixture of beta and 
alpha1 serum lipoproteins, 
Large aliquots of an emulsion of serum freed of chylomicrons and coconut 
oil were incubated at 37°C.  for 2 hours and ultracentrifuged as in the prepa- 
ration of chylomicrons. The fat particles now showed the presence of minute 
amounts of beta and alpha1 serum lipoproteins in almost the same proportion 
as  found in  chylomicrons. "Finger prints"  of delipidized samples  of  chylo- 
microns and partides from serum-coconut oil emulsion gave similar, although 
not identical patterns. 
The data on "clearing factor" activity corroborated the finding that serum 
alpha1  lipoproteins are contained in chylomicrons and particles from serum- 
coconut oil  emulsion. These  two lipide particles,  partially delipidized, were 
both able to activate a  "clearing factor" system in vitro, a property exhibited 
only by intact or partially delipidized alpha1 serum lipoproteins. Clearing ac- 
tivity was satisfactorily determined by using an emulsion of coconut oil mixed 
in agar as a  substrate to give an opaque gel,  in which the diffusing enzyme 
showed its activity by areas of clearing. The results obtained by this technique 
were in agreement with those based on fall in optical density and non-esterified 
fatty acid production. 
Chemical analysis of serum chylomicrons showed a  concentration of cho- 
lesterol and phospholipides higher than could be accounted for by the attached 
beta and alpha1 serum lipoproteins. 
On the basis of these results the assumption is made that in the blood stream 
small amounts of serum lipoproteins, by a process of adsorption, form a com- 
plex with the absorbed triglycerides, cholesterol, and phospholipides, to pro- 
duce chylomicrons. 
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